UPDATE: Intrexon to Acquire Medistem for $26M
December 20, 2013 at 10:46 AM EST
Intrexon Corporation (NYSE: XON ) today announced that it has entered into a definitive agreement to acquire, for approximately $26 million, San Diego-based Medistem, Inc. (OTC: MEDS ) a pioneer in the development of Endometrial Regenerative Cells ("ERC" or "ERCs"), universal donor adult stem cells that stimulate new
